Meet the experts : Tyler J
10.1002/jbmr.2564 Summary Keywords glucagonlike peptide1 receptor agonist, randomized controlled trial, older adults, bone mineral density, bone turnover Citation Dinkla L, Beavers KM, Robbins R, Akpalu D, Wherry SJ, Miller G, Beavers DP, Espinoza S, Trejo J, Stepanenko A and Cortes TM (2025) Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis
STEP 4 showed that maintained weight loss requires continued therapy
The findings were confirmed in a separate German cohort of 213 patients with biopsy-confirmed MASLD and F2-F3 fibrosis
and (4) mitochondrial support for neuronal repair via ALCAR.*